KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Bio-Rad Laboratories (BIO) over the last 17 years, with Q4 2025 value amounting to $1.0 billion.

  • Bio-Rad Laboratories' Short-term Investments fell 1406.83% to $1.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year decrease of 1406.83%. This contributed to the annual value of $1.0 billion for FY2025, which is 1406.83% down from last year.
  • As of Q4 2025, Bio-Rad Laboratories' Short-term Investments stood at $1.0 billion, which was down 1406.83% from $1.0 billion recorded in Q3 2025.
  • In the past 5 years, Bio-Rad Laboratories' Short-term Investments ranged from a high of $1.4 billion in Q1 2023 and a low of $346.4 million during Q1 2021
  • In the last 5 years, Bio-Rad Laboratories' Short-term Investments had a median value of $1.2 billion in 2023 and averaged $1.1 billion.
  • Its Short-term Investments has fluctuated over the past 5 years, first crashed by 2002.82% in 2021, then skyrocketed by 26696.6% in 2022.
  • Bio-Rad Laboratories' Short-term Investments (Quarter) stood at $399.1 million in 2021, then surged by 239.85% to $1.4 billion in 2022, then decreased by 11.29% to $1.2 billion in 2023, then decreased by 2.24% to $1.2 billion in 2024, then decreased by 14.07% to $1.0 billion in 2025.
  • Its Short-term Investments was $1.0 billion in Q4 2025, compared to $1.0 billion in Q3 2025 and $1.0 billion in Q2 2025.